Researchers tested whether a digital support program was practical for women who recently finished treatment for early-stage breast or gynecologic cancer. The study involved 200 women in Ireland. Half used a digital platform to report symptoms like fatigue every two months. If their scores were concerning, it triggered a check-in from a nurse and dietitian. The other half received their usual care.
The main goal was to see if running this program was feasible. The trial successfully met targets for enrolling women, getting them to complete the digital surveys, and having healthcare professionals respond. As a secondary finding, the women using the digital program reported statistically significant improvements in their fatigue, anxiety, depression, and overall quality of life scores compared to the usual care group.
It's important to understand this was a feasibility trial. Its main purpose was to test if the program could be run, not to prove it works better than standard care. The study did not report how large the improvements were or if there were any safety issues. The results are encouraging but preliminary. A much larger study is needed to see if this digital approach should become a regular part of cancer survivorship care.
